Recently Featured

Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior

September 30, 2026
With support from the National Institutes of Health, researchers have unveiled a groundbreaking laboratory model that elucidates the migration, maturation, and survival of antibody-producing plasma cells within human bone marrow. This innovative platform integrates a lymph node organoid with a bone marrow tissue chip, facilitating in-depth studies of plasma cell development stages. The findings are…

U.S. Officials Declare End to Record-Setting Cyclospora Outbreak, Origin Remains Unknown

September 30, 2026
NEW YORK — The largest cyclospora food poisoning outbreak in U.S. history has officially concluded, according to recent statements from U.S. health officials. This announcement comes as the U.S. Food and Drug Administration confirmed that all recalled iceberg lettuce associated with the outbreak has been removed from the market. Despite the resolution of the outbreak,…

Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results

September 29, 2026
Newly revealed global phase 3 data from Merck and Gilead’s Trodelvy trial in first-line non-small cell lung cancer (NSCLC) has highlighted a significant discrepancy in outcomes between Chinese and Western patient populations. While the trial did not meet its primary endpoints in the global cohort, the results from the Chinese subset demonstrated a more favorable…

CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice

September 29, 2026
Researchers at Johns Hopkins Medicine have unveiled CloudScope, a groundbreaking cloud-based miniaturized microscope that allows for the continuous monitoring of brain activity in freely moving mouse models for over 24 hours. This innovation addresses a significant challenge in neuroscience: the need for prolonged observation of biological processes in the brain, which are critical for understanding…

Ongoing Cases